Autopsy report · NCT01292941

Clinical Study Evaluating Safety of a New Catheter for Urinary Intermittent Catheter in Healthy Volunteers

“Product development project closed prematurely”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1

Sponsor

Coloplast A/S

Sponsor type

Industry

Conditions

Spinal Cord Injury

Interventions

Intermittent catheterisation; NonCE marked intermittent catheter/red; NonCE marked intermittent catheter/green; NonCE marked intermittent catheter/blue

Participants

0

Sites

1

Countries

Denmark

Trials that died the same way

• Safety and Pharmacokinetics of UV-4B Solution Administered Orally as Multiple Ascending Doses to Healthy Subjects
  “Product development halted for business reasons.” (67% match in meaning)
• Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 4)
  “Due to a change in the development program, the study was closed prematurely.” (67% match in meaning)
• Guiding Evidence Based Therapy Using Biomarker Intensified Treatment
  “Project was stopped due to futility” (63% match in meaning)
• Clinical Evaluation of Systane® Balance in Dry Eye Subjects
  “Discontinuation of product development” (61% match in meaning)
• A Study to Compare the Efficacy and Safety of JHL1101 Versus Rituximab in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL)
  “The development was stopped due to company's strategy consideration” (60% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.